Listed on the Italian Stock Exchange since May 2006, Pierrel is today a global provider to the pharmaceutical and life science industries, specialized in clinical development, registration and licensing of new drugs or formulations and in pharmaceutical production , through its Contract Research, Contract Manufacturing and Pharma Divisions.
Pierrel Group, with over 60 years of experience in the pharmaceutical sector, is one of the main European manufacturers of local and dental anesthetic drug products. Pierrel SpA has been listed on the Italian Stock Exchange market since 2006
Pierrel Pharma S.r.l. is responsible for sales and marketing of Orabloc worldwide, incluse the USA and Canada, through a network of established and respected distributors of dental products.
Our CRO division, Pierrel Research International AG in Thalwill near Zurigo, with more than 20 subsidiaries operates both in Europe and the USA, provides regulatory consulting and full operational services for research and development of new molecules and drug units.
Visit Pierrel S.p.A. website at: